The microbiome industry is experiencing rapid growth and transformation, driven by advancements in sequencing technologies, increased funding, and innovative research. This blog article compiles 40 key statistics that highlight the significant changes and trends in the microbiome field in 2024. Covering aspects from market size and segmentation to machine learning applications and insights from major...
Grabrucker S, Marizzoni M, Silajdžić E, et al. Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis. Brain. 2023;146:4916-4934. https://doi.org/10.1093/brain/awad303 Our metabolomics capabilities were recently highlighted in an Alzheimer’s Fecal Microbiota Transplant (FMT) study published in BRAIN by researchers at University College Cork in Ireland. By utilizing untargeted metabolomics, Grabrucker, Marizzoni, and colleagues underpinned novel microbiome-mediated mechanisms...
The human skin microbiome, a complex and diverse ecosystem of microorganisms, plays a crucial role in maintaining healthy skin. Understanding and improving this delicate balance can lead to better skin health and overall well-being. This article delves into the key insights about the skin microbiome and provides actionable tips to enhance it.
In the realm of microbiology, accurately identifying bacterial species is crucial for understanding microbial communities, diagnosing infections, and guiding treatment strategies. Traditional methods of bacterial identification, such as culture-based techniques, have limitations in providing rapid and comprehensive identification, especially for clinically unidentifiable bacterial isolates.
In the realm of microbiology, understanding the intricate workings of microbial communities has become a cornerstone of scientific inquiry. Two powerful tools, metatranscriptomics and metagenomics, have emerged as indispensable techniques for unravelling the complexities of microbial ecosystems. In this article, we delve into the nuances of these methodologies, exploring their differences, advantages, and applications.
Offering Unparalleled Resolution and Quality in Microbial Analysis Copenhagen, Denmark — April 23, 2024 — Clinical Microbiomics, a leader in microbiome analysis, announces the launch of its advanced long-read sequencing services. Tailored to meet the stringent requirements of academic, clinical, and industrial researchers, the expanded offerings deliver unmatched insights into microbial communities, featuring the industry’s...
Durham, NC (March 21, 2024 ) – Resilient Biotics, a leading microbiome platform company with a pipeline of products for maintaining respiratory tract health, is thrilled to announce a groundbreaking collaboration with CosmosID, a renowned microbiome analytics company. This joint effort aims to explore the intricate microbiome strains that colonize the respiratory tract tissues, a...
Clinical Microbiomics A/S^1, the global microbiome science company, today announces the acquisition of DNASense ApS, an innovative Danish microbiome CRO specialized in long-read DNA and RNA sequencing technologies, and the associated cutting-edge bioinformatics.
In the intricate world of microbiology and bacterial identification, 16S sequencing plays a pivotal role. But a common query often perplexes scientists and enthusiasts alike: Does 16S sequencing target RNA or DNA? This article will unravel the mysteries surrounding amplicon sequencing, exploring its role in bacterial identification, the distinction between 16S rRNA and whole genome...
Microbial growth is a dynamic and intricate process crucial for the survival and proliferation of bacterial cells. Understanding the sequential order of microbial growth stages is fundamental for researchers, microbiologists, and anyone delving into the fascinating realm of microbiology. In this comprehensive guide, we will explore the four stages of microbial growth—lag, exponential (log), stationary,...
© 2023 CosmosID. All rights reserved